SARS-CoV-2 Quality Solutions

 

LGC SeraCare has provided gold standard third-party run controls and reference materials to clinical laboratories for more than 30 years. We are committed to supporting the critical efforts of assay development, verification, and ongoing performance monitoring in response to the COVID-19 pandemic. Our quality solutions encompass both molecular and serology performance monitoring tools to support early detection of infection and antibody surveillance efforts.


Learn more about our 
SARS-CoV-2 Molecular (PCR) and Serology solutions

  Molecular_PCR_SolutionsSerology-Solutions

Learn more about our SARS-CoV-2, Flu A/B, and RSV multiplexed solutions

SARS-COV-2_Multiplexed_Solutions

 

The Native Antigen Company is now part of the LGC Clinical Diagnostics Division and specializes in the development and manufacture of native and recombinant viral and bacterial antigens and antibodies. The Company has decades of experience in producing high-quality proteins with its proprietary mammalian cell expression system which ensures correct glycosylation and proper folding for the development of highly specific assays. For more information on The Native Antigen Company visit: thenativeantigencompany.com

Learn more New SARS-CoV-2 Spike Monoclonal Antibodies solutions

SARS-COV-2_Monoclonal-Antibodies_Solutions

*clicking on the above button will direct you to LGC's The Native Antigen Company website to learn more.